Zynex Inc Stock Investor Sentiment

ZYXI Stock  USD 7.54  0.03  0.40%   
Under 75% of Zynex's investor base is looking to short. The analysis of overall sentiment of trading Zynex Inc stock suggests that many investors are alarmed at this time. Zynex's investing sentiment shows overall attitude of investors towards Zynex Inc.
  

Zynex Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Zynex can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over three months ago at news.google.com         
Zynex, Inc. 2025 Looks Like A Brighter Year - Seeking Alpha
Google News at Macroaxis
over three months ago at finance.yahoo.com         
Investors in Zynex have unfortunately lost 22 percent over the last five years
Yahoo News
over three months ago at news.google.com         
Zynexs SWOT analysis pain management firms stock faces growth hurdles - Investing.com
Google News at Macroaxis
over three months ago at news.google.com         
Northland starts Zynex shares coverage with Outperform on positive outlook - Investing.com
Google News at Macroaxis
over three months ago at www.macroaxis.com         
Disposition of 15000 shares by Daniel Moorhead of Zynex at 8.24 subject to Rule 16b-3
Macroaxis News
over three months ago at www.macroaxis.com         
Disposition of 185 shares by Anna Lucsok of Zynex at 8.41 subject to Rule 16b-3
Macroaxis News
over three months ago at www.macroaxis.com         
Acquisition by Daniel Moorhead of 5000 shares of Zynex subject to Rule 16b-3
Macroaxis News
over three months ago at finance.yahoo.com         
In spite of recent selling, insiders still have the largest holding in Zynex, Inc. with a 51 percent...
Yahoo News
over three months ago at www.macroaxis.com         
Disposition of 5250 shares by Daniel Moorhead of Zynex at 7.89 subject to Rule 16b-3
Macroaxis News
over three months ago at finance.yahoo.com         
Zynex to Present at the HC Wainwright Global Investment Conference
Yahoo News
over three months ago at finance.yahoo.com         
Zynex Obtains FDA clearance for new Pain Management Device
Yahoo News
over three months ago at seekingalpha.com         
Zynex wins FDA nod for pain management device
seekingalpha News
over six months ago at finance.yahoo.com         
Zynexs Returns On Capital Not Reflecting Well On The Business
Yahoo News
over six months ago at simplywall.st         
Zynex Chief Operating Officer Anna Lucsok Sells 59 percent Of Holding
Simply Wall St News at Macroaxis
over six months ago at gurufocus.com         
Insider Sale COO Anna Lucsok Sells 24,875 Shares of Zynex Inc
Gurufocus Stories at Macroaxis
Far too much social signal, news, headlines, and media speculation about Zynex that are available to investors today. That information is available publicly through Zynex media outlets and privately through word of mouth or via Zynex internal channels. However, regardless of the origin, that massive amount of Zynex data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Zynex news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Zynex relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Zynex's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Zynex alpha.

Zynex Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Disposition of 2000 shares by Thomas Sandgaard of Zynex at 8.67 subject to Rule 16b-3
11/21/2024
2
Disposition of 10000 shares by Daniel Moorhead of Zynex at 8.08 subject to Rule 16b-3
12/02/2024
3
Insider Sell Alert Daniel Moorhead Sells 10,000 Shares of Zynex Inc
12/04/2024
4
Daniel J. Moorhead Sells 10,000 Shares of Zynex, Inc. Stock
12/05/2024
5
Zynexs SWOT analysis pain management firms stock faces growth hurdles
12/10/2024
6
Zynex Announces Partnership To Conduct Business with Veterans Affairs Medical Centers, the Largest Healthcare Network in the United States
12/17/2024
7
Disposition of 10000 shares by Daniel Moorhead of Zynex at 7.88 subject to Rule 16b-3
01/02/2025
8
Pivots Trading Plans and Risk Controls - Stock Traders Daily
01/08/2025
9
Acquisition by Anna Lucsok of 2764 shares of Zynex subject to Rule 16b-3
01/15/2025
10
Disposition of 7911 shares by Anna Lucsok of Zynex at 8.19 subject to Rule 16b-3
01/27/2025
11
Disposition of 10000 shares by Daniel Moorhead of Zynex at 7.68 subject to Rule 16b-3
02/03/2025
12
Insider Sell Daniel Moorhead Sells 10,000 Shares of Zynex Inc
02/04/2025
13
With 47 percent ownership, Zynex, Inc. insiders have a lot at stake
02/13/2025

Complementary Tools for Zynex Stock analysis

When running Zynex's price analysis, check to measure Zynex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zynex is operating at the current time. Most of Zynex's value examination focuses on studying past and present price action to predict the probability of Zynex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zynex's price. Additionally, you may evaluate how the addition of Zynex to your portfolios can decrease your overall portfolio volatility.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences